Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 18 | 2025 | 1113 | 1.800 |
Why?
|
| Heart Ventricles | 7 | 2023 | 761 | 1.050 |
Why?
|
| Heart-Assist Devices | 6 | 2024 | 1045 | 0.860 |
Why?
|
| Calcinosis | 3 | 2012 | 184 | 0.820 |
Why?
|
| Heart Failure | 9 | 2024 | 2287 | 0.780 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 2 | 2012 | 42 | 0.710 |
Why?
|
| Emergency Medicine | 1 | 2022 | 165 | 0.630 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 197 | 0.600 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 33 | 0.590 |
Why?
|
| Echocardiography, Transesophageal | 8 | 2013 | 252 | 0.590 |
Why?
|
| Mitral Valve | 5 | 2012 | 250 | 0.560 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2013 | 149 | 0.530 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2012 | 154 | 0.510 |
Why?
|
| Cardiology | 6 | 2024 | 486 | 0.500 |
Why?
|
| Systole | 4 | 2023 | 193 | 0.420 |
Why?
|
| Radiology | 1 | 2015 | 118 | 0.410 |
Why?
|
| Incidental Findings | 2 | 2012 | 121 | 0.410 |
Why?
|
| Thrombosis | 3 | 2012 | 502 | 0.390 |
Why?
|
| Societies, Medical | 4 | 2025 | 738 | 0.390 |
Why?
|
| Sinus of Valsalva | 1 | 2013 | 32 | 0.390 |
Why?
|
| Ablation Techniques | 1 | 2012 | 31 | 0.360 |
Why?
|
| Pericardium | 1 | 2013 | 103 | 0.360 |
Why?
|
| Aortic Rupture | 1 | 2013 | 114 | 0.360 |
Why?
|
| American Heart Association | 4 | 2022 | 307 | 0.350 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2020 | 428 | 0.340 |
Why?
|
| Ethanol | 1 | 2012 | 159 | 0.330 |
Why?
|
| Ventricular Function, Left | 4 | 2024 | 515 | 0.320 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2013 | 115 | 0.310 |
Why?
|
| Myocardial Ischemia | 3 | 2014 | 299 | 0.310 |
Why?
|
| Quality Assurance, Health Care | 4 | 2013 | 202 | 0.310 |
Why?
|
| Fluorocarbons | 2 | 2008 | 61 | 0.280 |
Why?
|
| Methemoglobinemia | 1 | 2008 | 9 | 0.280 |
Why?
|
| Pericarditis, Constrictive | 1 | 2008 | 6 | 0.280 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 34 | 0.270 |
Why?
|
| Palliative Care | 1 | 2012 | 441 | 0.270 |
Why?
|
| Cardiac Tamponade | 1 | 2008 | 37 | 0.270 |
Why?
|
| Tricuspid Valve | 1 | 2008 | 62 | 0.270 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2008 | 65 | 0.270 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 87 | 0.270 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 71 | 0.260 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2008 | 77 | 0.260 |
Why?
|
| Hematoma | 1 | 2008 | 89 | 0.260 |
Why?
|
| Cor Triatriatum | 1 | 2007 | 10 | 0.260 |
Why?
|
| Humans | 44 | 2025 | 126679 | 0.250 |
Why?
|
| Contrast Media | 2 | 2012 | 459 | 0.250 |
Why?
|
| Prosthesis Implantation | 2 | 2024 | 151 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 200 | 0.240 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 494 | 0.220 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2006 | 133 | 0.220 |
Why?
|
| Diagnostic Imaging | 3 | 2013 | 278 | 0.220 |
Why?
|
| Albumins | 1 | 2005 | 89 | 0.220 |
Why?
|
| Vascular Resistance | 2 | 2024 | 184 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1162 | 0.210 |
Why?
|
| Heart Septum | 1 | 2003 | 44 | 0.210 |
Why?
|
| Heart Neoplasms | 1 | 2005 | 104 | 0.210 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 110 | 0.200 |
Why?
|
| Aortic Valve | 2 | 2020 | 443 | 0.200 |
Why?
|
| Ventricular Function, Right | 2 | 2022 | 120 | 0.200 |
Why?
|
| Heart Valve Prosthesis | 3 | 2004 | 294 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2012 | 358 | 0.190 |
Why?
|
| Chest Pain | 2 | 2022 | 124 | 0.190 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 180 | 0.190 |
Why?
|
| Sarcoma | 1 | 2005 | 205 | 0.190 |
Why?
|
| Advisory Committees | 2 | 2013 | 145 | 0.190 |
Why?
|
| United States | 13 | 2025 | 11297 | 0.180 |
Why?
|
| Ultrasonography | 3 | 2022 | 933 | 0.180 |
Why?
|
| Cardiovascular Diseases | 5 | 2013 | 2036 | 0.170 |
Why?
|
| Adult | 15 | 2025 | 30379 | 0.170 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 442 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 1255 | 0.170 |
Why?
|
| Thrombolytic Therapy | 2 | 2004 | 205 | 0.170 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2002 | 173 | 0.170 |
Why?
|
| Echocardiography, Doppler | 3 | 2010 | 165 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2013 | 382 | 0.160 |
Why?
|
| Male | 20 | 2024 | 62490 | 0.160 |
Why?
|
| Exercise Test | 1 | 2001 | 243 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2001 | 172 | 0.150 |
Why?
|
| Diastole | 1 | 1999 | 172 | 0.140 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 19 | 0.140 |
Why?
|
| Heart | 1 | 2022 | 650 | 0.140 |
Why?
|
| Echocardiography, Stress | 2 | 2008 | 18 | 0.140 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1998 | 33 | 0.140 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 207 | 0.140 |
Why?
|
| Vagus Nerve | 1 | 2017 | 45 | 0.130 |
Why?
|
| Nebivolol | 1 | 2016 | 4 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 1998 | 147 | 0.130 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2016 | 14 | 0.130 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 334 | 0.130 |
Why?
|
| Heart Diseases | 3 | 2010 | 490 | 0.130 |
Why?
|
| Female | 17 | 2024 | 68275 | 0.130 |
Why?
|
| Metoprolol | 1 | 2016 | 21 | 0.130 |
Why?
|
| Hemodynamics | 3 | 2013 | 822 | 0.130 |
Why?
|
| Middle Aged | 12 | 2024 | 27672 | 0.130 |
Why?
|
| Microspheres | 2 | 2008 | 68 | 0.120 |
Why?
|
| Defibrillators, Implantable | 2 | 2013 | 211 | 0.120 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2013 | 19 | 0.120 |
Why?
|
| Heart Conduction System | 1 | 2017 | 155 | 0.120 |
Why?
|
| Risk Assessment | 6 | 2024 | 3583 | 0.120 |
Why?
|
| Botulinum Toxins | 1 | 2017 | 124 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2022 | 2225 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2024 | 12537 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 254 | 0.100 |
Why?
|
| Biomedical Technology | 1 | 2013 | 34 | 0.100 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 37 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2013 | 61 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2012 | 581 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 5113 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2014 | 453 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 85 | 0.090 |
Why?
|
| Laboratories, Hospital | 1 | 2011 | 24 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1859 | 0.080 |
Why?
|
| Aspirin | 1 | 2012 | 209 | 0.080 |
Why?
|
| Aged | 8 | 2024 | 20321 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2024 | 16985 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 711 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2010 | 613 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3693 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1136 | 0.070 |
Why?
|
| Pericardiectomy | 1 | 2008 | 10 | 0.070 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Heart Transplantation | 2 | 2024 | 866 | 0.070 |
Why?
|
| Cyanosis | 1 | 2008 | 42 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2008 | 358 | 0.060 |
Why?
|
| Oximetry | 1 | 2008 | 174 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 168 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 184 | 0.060 |
Why?
|
| Coronary Disease | 3 | 2008 | 640 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 240 | 0.060 |
Why?
|
| Anesthetics, Dissociative | 1 | 2004 | 18 | 0.050 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2024 | 26 | 0.050 |
Why?
|
| Radiography | 1 | 2006 | 752 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 6663 | 0.050 |
Why?
|
| Death, Sudden | 1 | 2003 | 44 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 429 | 0.050 |
Why?
|
| Utilization Review | 2 | 2013 | 40 | 0.050 |
Why?
|
| Decision Making | 3 | 2014 | 664 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 214 | 0.050 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2002 | 32 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2013 | 967 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2024 | 223 | 0.050 |
Why?
|
| Risk Factors | 3 | 2024 | 10545 | 0.050 |
Why?
|
| Health Services Research | 2 | 2013 | 175 | 0.050 |
Why?
|
| Organ Size | 1 | 2022 | 429 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2007 | 750 | 0.040 |
Why?
|
| Video Recording | 1 | 2002 | 200 | 0.040 |
Why?
|
| Ketamine | 1 | 2004 | 223 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1221 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 1193 | 0.040 |
Why?
|
| Patient Safety | 2 | 2014 | 434 | 0.040 |
Why?
|
| Dobutamine | 1 | 1999 | 54 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 402 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 2109 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2020 | 413 | 0.030 |
Why?
|
| Algorithms | 2 | 2014 | 1633 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 224 | 0.030 |
Why?
|
| Warfarin | 1 | 1998 | 122 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 115 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 536 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2969 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 150 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 120 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 1995 | 25 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 400 | 0.030 |
Why?
|
| Prognosis | 3 | 1999 | 4772 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6126 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 508 | 0.030 |
Why?
|
| Mutation | 1 | 2008 | 5939 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1595 | 0.030 |
Why?
|
| Hypotension | 1 | 1995 | 182 | 0.030 |
Why?
|
| Coronary Occlusion | 1 | 2013 | 31 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2013 | 126 | 0.030 |
Why?
|
| Vascular Calcification | 1 | 2013 | 65 | 0.020 |
Why?
|
| Cattle | 2 | 2004 | 537 | 0.020 |
Why?
|
| Mass Screening | 2 | 2008 | 802 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 609 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 533 | 0.020 |
Why?
|
| Animals | 4 | 2017 | 33045 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2010 | 128 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 19987 | 0.020 |
Why?
|
| Myocardium | 1 | 2014 | 847 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 433 | 0.020 |
Why?
|
| Regional Health Planning | 1 | 2008 | 6 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 76 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1559 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 839 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2008 | 99 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 130 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 849 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 4426 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2008 | 354 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 711 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 36 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2007 | 395 | 0.010 |
Why?
|
| Reference Standards | 1 | 2004 | 228 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2039 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2004 | 629 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 1532 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1995 | 495 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 3063 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 604 | 0.010 |
Why?
|
| Survival Rate | 1 | 1995 | 2100 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1995 | 6203 | 0.000 |
Why?
|